Company
Headquarters: Nanaimo, BC, Canada
Founded: 2013
Employees: 1,800
CEO: Mr. Irwin David Simon
$1.05 Billion
USD as of Jan. 1, 2025
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. It offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. The company operates Tilray Medical, a medical platform that provides GMP-certified flowers, oils, vapes, edibles, and topicals. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Tilray, Inc. Tilray Brands Inc. was incorporated in 2018 and is headquartered in New York, New York.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Last Financial Reports Date | Nov. 30, 2024 |
Revenue TTM | $812.0 M |
EBITDA | $31.1 M |
Gross Profit TTM | $246.2 M |
Profit Margin | -26.18% |
Operating Margin | -14.69% |
Quarterly Revenue Growth | 13.10% |
Tilray, Inc. has the following listings and related stock indices.
Stock: NASDAQ: TLRY wb_incandescent
Stock: FSX: 2HQ wb_incandescent
Stock: TSX: TLRY wb_incandescent
Founder(s): Brendan Kennedy